| Original language | English (US) |
|---|---|
| Pages (from-to) | 1475-1476 |
| Number of pages | 2 |
| Journal | Journal of Allergy and Clinical Immunology: In Practice |
| Volume | 8 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2020 |
ASJC Scopus subject areas
- Immunology and Allergy
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, No. 5, 05.2020, p. 1475-1476.
Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - JACI
T2 - In Practice Response to COVID-19 Pandemic
AU - Angel, Dawn M.
AU - Zeiger, Robert S.
AU - Sicherer, Scott H.
AU - Khan, David A.
AU - Schatz, Michael
N1 - Funding Information: Conflicts of interest: D. M. Angel is Managing Editor of the Journal of Allergy and Clinical Immunology: In Practice. R. S. Zeiger reports grants from the National Institutes of Health, ALK Pharma, Genentech, MedImmune/AstraZeneca, Merck & Co., and Teva to Kaiser Permanente Southern California; personal fees from the American Academy of Allergy, Asthma & Immunology as Deputy Editor of the Journal of Allergy and Clinical Immunology: In Practice, American College of Allergy, Asthma & Immunology, AstraZeneca, DBV Technologies, Genentech, Novartis, GlaxoSmithKline, and Regeneron Pharmaceuticals; and royalty payments from UpToDate. S. H. Sicherer reports royalty payments from UpToDate and from Johns Hopkins University Press; grants to his institution from the National Institute of Allergy and Infectious Diseases, from Food Allergy Research and Education, and from HAL Allergy; and personal fees from the American Academy of Allergy, Asthma & Immunology as Deputy Editor of the Journal of Allergy and Clinical Immunology: In Practice, outside of the submitted work. D. A. Khan is Associate Editor of the Journal of Allergy and Clinical Immunology: In Practice. M. Schatz is Editor-in-Chief of the Journal of Allergy and Clinical Immunology: In Practice and receives royalty payments from UpToDate and research grants to his institution from ALK, Merck, and Teva Pharmaceuticals.
PY - 2020/5
Y1 - 2020/5
UR - http://www.scopus.com/inward/record.url?scp=85083793944&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083793944&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2020.03.027
DO - 10.1016/j.jaip.2020.03.027
M3 - Editorial
C2 - 32272283
AN - SCOPUS:85083793944
SN - 2213-2198
VL - 8
SP - 1475
EP - 1476
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 5
ER -